Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq 04:00:00 2024-09-12 pm EDT 5-day change 1st Jan Change
8.840 USD +1.14% Intraday chart for Walgreens Boots Alliance, Inc. +1.14% -66.14%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
TD Cowen Cuts Price Target on Walgreens Boots Alliance to $16 From $22 MT
Transcript : Walgreens Boots Alliance, Inc. Presents at TD Cowen 9th Annual FutureHealth Conference, Sep-10-2024 04:10 PM
Wintrust Financial Corporation Appoints Gina Stuart as Its New SVP, Diversity, Equity, and Inclusion CI
BJ's Restaurants, Inc. Announces Appointment of Lyle D. Tick as President & Chief Concept Officer CI
JPMorgan Adjusts Walgreens Boots Alliance's PT to $15 From $20, Maintains Overweight Rating MT
Evercore ISI Lowers Price Target on Walgreens Boots Alliance to $7.50 From $10, Keeps In Line Rating MT
Walgreens Boots Alliance Forms Partnership With Bilt Rewards; Shares Rise MT
Walgreens Announces Executive Appointments CI
Cencora's cure-all: A dose of data and distribution Our Logo
Walgreens Collaborating With US Drug Research Authority to Boost Clinical Trials MT
Harris' anti-price gouging plan could build on US state law RE
Walgreens Boots Alliance Prices $750 Million Notes Offering MT
Global markets live: Amazon, Intel, Boeing, Robinhood, KKR, Zillow... Our Logo
Nasdaq's wild mood swings Our Logo
Walgreens explores options for selling VillageMD business RE
Walgreens Mulls Sale of VillageMD DJ
Walgreens, Instacart Partner to Accept Online Snap/EBT Payments MT
Walgreens Plans to Sell Another Slice of Its Cencora Stake for $1.1 Billion CI
Global markets live: Wells Fargo, Nintendo, Apple, Amazon, Alphabet... Our Logo
Sector Update: Health Care Stocks Decline Premarket Friday MT
Walgreens Boots Alliance Sells Cencora Shares for $1.1 Billion MT
Walgreens further reduces stake in Cencora RE
Walgreens sells shares in Cencora for about $1.1 billion RE
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11 MT
GDP High, Nasdaq Sigh Our Logo
Chart Walgreens Boots Alliance, Inc.
More charts
Logo Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Employees
268,500
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
8.840USD
Average target price
12.43USD
Spread / Average Target
+40.63%
Consensus
  1. Stock Market
  2. Equities
  3. WBA Stock
  4. News Walgreens Boots Alliance, Inc.
  5. Walgreens, Instacart Partner to Accept Online Snap/EBT Payments
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW